Tizanidine
- Product NDC
- 70518-1439
- 11-digit product format
- 705181439
- Labeler code
- 70518
- Product ID
- 70518-1439_e42b1a10-0789-7947-e053-2a95a90ae3d7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA076416
- Marketing category
- ANDA
- Marketing start
- 2018-09-27
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-1439-2 | 70518143902 | 90 TABLET in 1 BOTTLE, PLASTIC (70518-1439-2) | 90 tablet | 2020-04-13 | 0000-00-00 | No | No | Current |
| 70518-1439-3 | 70518143903 | 20 TABLET in 1 BOTTLE, PLASTIC (70518-1439-3) | 20 tablet | 2020-12-23 | 0000-00-00 | No | No | Current |